ReviewEULAR rheumatology open2026
New treatments in myositis on the horizon.
Review in EULAR rheumatology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The idiopathic inflammatory myopathies (IIM), or briefly myositis, are a heterogeneous group of rare autoimmune diseases with high morbidity and mortality. Current treatment is based on high doses of glucocorticoids over long periods of time in combination with immunosuppressive drugs, with varying and often disappointing results. Therefore, there is a high unmet need for new therapies. Subgrouping patients with IIM based on clinical, histopathological and autoantibody profiles has facilitated identification of predominant molecular pathways, and this knowledge has been applied in recent successful clinical trials, and more trials are in the pipeline. This is exciting and promising news indicating possibilities to improve health and life for patients with IIM.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.